New report looks at medications being developed for Alzheimer's treatment

July 10, 2019 06:09 PM

More than five million Americans are living with Alzheimer's disease - and awaiting new medications to treat it.  We often hear the Alzheimer's drug development pipeline is dry, but that's not necessarily true. A new report looks at drugs being developed, how far along they are, and how they work.

Earlier this year, researchers experienced a major setback when a highly anticipated drug failed.

Advertisement – Content Continues Below

The drug targeted amyloid - a type of protein linked to Alzheimer's that accumulates in the brain.

Experts say while these types of drugs aren't making as much progress as researchers had hoped, there are new ideas and products moving forward. 

"I hear over and over when I give talks around the country, there's nothing going on, there's no hope, there's nothing, no progress being made, when I know that this is an $8 billion industry and there's massive amounts of research going on to the tune of 75 drugs in clinical trials right now," said Dr. Marwan Sabbagh, with Cleveland Clinic Lou Ruvo Center for Brain Health.

Although there's no cure for Alzheimer's yet, Dr. Sabbagh says every discovery leads science in the right direction.


WNYT Staff

Copyright 2019 WNYT-TV LLC, a Hubbard Broadcasting Company. All rights reserved

Albany community looks for ways to prevent gun violence

Army of volunteers join cleanup at overgrown Albany cemetery

Mueller takes the TV stage; Democrats hope America tunes in

Senate approves bill to extend 9/11 victims fund

Schenectady police introduce new program to help addicts